Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03224650 · ClinicalTrials.gov registry record
Validation of Novel Predictive Score for Patients With Spinal Metastases
A clinical trial of Spinal Metastases, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 219
- Enrollment target
- 1
- Study location
NCT03224650 is a study of Spinal Metastases that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 219 participants, above the 74-participant average among 5 other Spinal Metastases trials with a reported enrollment target (196% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03224650, a study of Spinal Metastases, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 219 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are prospectively validating a prognostic clinical tool that uses a patient's modified Bauer grade, ambulatory status, and pre-operative serum albumin to predict survival, post-treatment morbidity, and functional outcomes in patients with metastatic disease involving the spine.
Conditions Studied
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 219 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2022-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03224650
The ClinicalTrials.gov registry entry for NCT03224650 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 219 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 74-participant average among 5 other Spinal Metastases trials with a reported enrollment target (196% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Spinal Metastases appearing as the primary indexed condition, and to 0 interventions.
NCT03224650 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03224650 about?
NCT03224650 is a clinical study titled "Validation of Novel Predictive Score for Patients With Spinal Metastases". The investigators are prospectively validating a prognostic clinical tool that uses a patient's modified Bauer grade, ambulatory status, and pre-operative serum albumin to predict survival, post-treatment morbidity, and functional outcomes in patients with metastatic disease involving the spine.
What is the current status of trial NCT03224650?
This trial is currently completed. The enrollment target is 219 participants. The study started on 2017-07-01. Estimated completion is 2022-01-31.
What conditions does trial NCT03224650 study?
This clinical trial studies the following conditions: Spinal Metastases.
Who is sponsoring clinical trial NCT03224650?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03224650 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Metastases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
D20054;LITT for Spine Tumors
RECRUITING · NA
-
Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases
RECRUITING · Phase 3
-
A Prospective Study of Performing MRI Simulation in Treatment Position in Spinal Stereotactic Body Radiation Therapy
ACTIVE NOT RECRUITING
-
Intra-arterial Chemotherapy for Spinal Metastases
COMPLETED · Phase 1
-
Stereotactic Body Radiotherapy for Spine Tumors
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.